我们的网站为什么显示成这样?

可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:

|本期目录/Table of Contents|

慢性充血性心力衰竭抗醛固酮治疗对神经内分泌和性激素的影响(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2007年第2期
页码:
205-208
栏目:
临床研究
出版日期:
2007-04-01

文章信息/Info

Title:
Effect of antialdosterone on neuroendocrine hormone and sex hormone in treatment of chronic congestive heart failure
作者:
王继征王凤阚国庆张国清李广军
山东枣庄矿业集团枣庄医院心内科,山东 枣庄 277100
Author(s):
WANG Jizheng WANG Feng KAN Guoqing ZHANG Guoqing LI Guangjun
Department of Cardiology, Zaozhuang Hospital, Zaozhuang Mining (Group ) Co. Ltd, Zaozhuang, 277100, Shandong,China
关键词:
心力衰竭充血性神经内分泌性激素螺内酯
Keywords:
heart failurecongestive neuroendocrine hormone sex hormone spironolaction
分类号:
R541.6
DOI:
-
文献标识码:
A
摘要:
目的 探讨慢性充血性心力衰竭(CHF)抗醛固酮治疗对神经内分泌激素和性激素的影响。方法 心功能(NYHA分级)Ⅱ~Ⅳ级的CHF患者136例随机分为两组,对照组给予强心、利尿剂、血管紧张素转换酶抑制剂(ACEI)、β受体阻滞剂等常规治疗;治疗组在常规治疗的基础上加用螺内酯40 mg/d,连用3个月。分别于入院后及3个月时,根据临床症状评价心功能;测定血浆血管紧张素Ⅱ(AngⅡ)、醛固酮(ALD)、雌二醇(E2)、睾酮(T)、肌酐、尿素氮、血钾、钠;心脏超声测定左室射血分数(LVEF)。结果 两组患者治疗3个月后血浆AngⅡ、ALD均有降低,治疗组尤为显著(P<0.01);与治疗前相比,治疗组E2升高,T降低,差异达显著性;治疗后两组心功能均有改善,治疗组更加明显;治疗组血钾明显升高;两组肾功能无明显改变。结论 螺内酯治疗可改善CHF患者神经内分泌激素和性激素水平,进一步改善临床预后。
Abstract:
AIM To investigate the effect of antialdosterone on neuroendocrine hormone and sex hormone in the treatment of chronic congestive heart failure (CHF). METHODS One hundred and thirtysix CHF patients with cardiac functions of Ⅱ~Ⅳ grade were randomized to either the control group or treatment group. The patients in control group received the routine treatment including digitalis, diuretics, ACEI and βblocking agents. The treatment group was given conventional treatment plus spironolaction 40 mg/d for three months. Assessments of cardiac function (NYHA class ) were made according to clinical symptoms. Before and three months after the treatment, angiotensin (AngⅡ), aldosterone (ALD), estradiol (E2),testosterone (T), creatinine, blood urea nitrogen, serum Kalium and serum Natrium were measured. Left ventricular ejection fraction was measured by echocardiography. RESULTS AngⅡand ALD were lower in the treatment group than those in the control group after three months (P<0.01). Higher E2 and lower T in the treatment group were significant after treatment. The cardiac function improved in both groups after three months and the improvement was more significant in the treatment group. Serum Kalium was higher in the treatment group and no significant changes in renal function were found in both groups. CONCLUSION Spironolaction therapy can improve neuroendocrine hormone and sex hormone in CHF patients and thus alleviate clinical symptom .

参考文献/References

[1] 颜红兵,柯元南.美国成人慢性心力衰竭诊断与治疗指南(2005年修订版)[M].北京:中国环境科学出版社,2005:7-10.

[2] McKelvie RS, Yusuf S, Pericak D, et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study.The RESOLVD Pilot Study Investigators[J]. Circulation,1999,100(10):1056-1064.

[3] McMahon EG. Recent studies with eplerenone. A novel selective aldosterone receptor antagonist[J]. Curr Opin Pharmacol, 2001,1(2):190-196.

[4] Zannad F. Angiotensinconverting enzyme inhabit and spironolactone combination therapy: new objectives in congestive heart failure treatment[J]. Am J Cardiol, 1993,71(suppl):34A-39A.

[5] Zannad F, Dousset B, Alla F. Treatment of congestive heart failure: interfering the aldosterone cardiac extracellular matrix relationship[J]. Hypertension, 2001,38(5):1227-1232.

[6] Pitt B, Zannad F, Remme WJ, et al. The effect of spironolactone on morbidity and mortality in patients with sever heart failure: Randomized Aldactone Evaluation Study Investigators[J]. N Engl J Med, 1999,341(10):709-717.

[7] Pitt B, Remme W, Zannad F,et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction[J]. N Eng J Med,2003,348(14):1309-1321.

[8] Hayward CS, Webb CM, Collins P. Effect of sex hormones on cardiac mass[J]. Lancet, 2001,357(9265):1354-1356.

备注/Memo

备注/Memo:
收稿日期:2006-04-17.通讯作者:王继征,副主任医师,主要从事心力衰竭的现代诊治及心血管介入治疗研究Email:2004zzwjz@163.com
更新日期/Last Update: